CELLULAR AND GENE THERAPIES
Anti-CD38-CAR-allogeneic gd T-cell therapy is expected to be a highly effective and feasible treatment for patients with relapsed and refractory myeloma as an off-the-shelf use.
Y. Hattori, N. Ohshima, Y.Taniguchi et al.
· 2 citations